Life Science News

RSS

Thermo Fisher Scientific announces record $2.84 billion revenue in fourth-quarter 2009

Thermo Fisher Scientific Inc., the world leader in serving science, reported that revenues increased 7% to a record $2.84 billion in the fourth quarter of 2009, compared with $2.65 billion in the 2008 quarter. The revenue growth reflects the impact of currency translation, which increased revenues by 3%, and the effect of acquisitions, which also increased revenues by 3%.

From Thermo Fisher Scientific Inc. 3 Feb 2010

Fluxion Biosciences to defend against alleged automated patch clamp system patent infringement lawsuit

Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in the field of automated ion channel screening systems for drug discovery. Cellectricon has asserted U.S. Patents Nos. 7,390,650, 7,470,518, and 7,563,614 in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros and licensed to Cellectricon.

From Fluxion Biosciences 3 Feb 2010

Cellectricon resumes litigation against Fluxion Biosciences over alleged patent infringement

Cellectricon AB today announced that it has resumed its litigation against Fluxion Biosciences, Inc. Cellectricon filed the lawsuit in July 2009 in the United States District Court for the Northern District of California alleging infringement of several United States patents issued or licensed to Cellectricon for microfluidic technology used in Cellectricon's state-of-the-art ion channel drug screening solution, the Dynaflow(R)HT System. Cellectricon's U.S. Patents Nos. 7,390,650, 7,470,518 and 7,563,614 have been asserted in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros, and licensed to Cellectricon.

From Fluxion Biosciences 2 Feb 2010

Thermo Fisher Scientific to acquire Finnzymes

Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has signed a definitive agreement to acquire Finnzymes, a well-recognized provider of integrated tools for molecular biology analysis, including reagents, instruments, consumables and kits. Headquartered in Espoo, Finland, Finnzymes has 90 employees and generated revenue of $20 million in 2009.

From Thermo Fisher Scientific Inc. 2 Feb 2010

Thermo Fisher Scientific provides public notice to the holders Floating Rate Convertible Senior Debentures

As required under the indenture covering Apogent Technologies Inc. Floating Rate Convertible Senior Debentures due 2033 (CUSIP No. 03760AAK7), Thermo Fisher Scientific Inc. is providing public notice to the holders of these bonds that they have the right to receive contingent interest for the current quarterly interest period ending March 15, 2010.

From Thermo Fisher Scientific Inc. 30 Jan 2010

CAMH signs licensing agreement to develop and market genetic test for degenerative muscle disorder

The Centre for Addiction and Mental Health (CAMH) has signed a licensing agreement with a Massachusetts firm to develop and market an innovative genetic test for a recently identified degenerative muscle disorder. The disorder tends to strike adults in their early 30s.

From Thermo Fisher Scientific Inc. 29 Jan 2010

Fluxion Biosciences expands its IonFlux automated patch clamp system

Fluxion Biosciences announced today a product expansion for its IonFlux automated patch clamp system which includes full automation and walk-away capability.

From Fluxion Biosciences 27 Jan 2010

Perkinelmer adds Atomax HCL to its consumables portfolio

PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the addition of the Atomax™ line of 1.5 inch hollow cathode lamps (HCL) to the Company’s atomic spectroscopy consumables portfolio.

From PerkinElmer 22 Jan 2010

Intrinsic Bioprobes licenses diabetes biomarkers to Ortho-Clinical Diagnostics

Intrinsic Bioprobes today announced the exclusive licensing of two novel biomarkers for diabetes to Ortho-Clinical Diagnostics, Inc. (Raritan, NJ). The biomarkers are modified forms of blood-circulating proteins and have been linked with the presence of pre-diabetes and type 2 diabetes. The financial terms of the licensing agreement were not disclosed.

From Ortho-Clinical Diagnostics, Inc. 22 Jan 2010

Thermo Fisher Scientific signs definitive agreement to acquire Ahura Scientific

Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has signed a definitive agreement to acquire Ahura Scientific, a leader in field-deployed analytical instruments for human health and public safety, for $145 million in cash plus the potential for an earn-out payment based on the achievement of certain 2010 financial targets.

From Thermo Fisher Scientific Inc. 19 Jan 2010

PerkinElmer introduces chromatography and spectroscopy products at Analytica 2010

PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, is introducing an extensive portfolio of chromatography and spectroscopy products at Analytica 2010 - Hall A2, stand 401.

From PerkinElmer 19 Jan 2010

PerkinElmer announces a suite of hyphenated solutions for EGA

PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced a suite of hyphenated solutions for Evolved Gas Analysis (EGA), or measurements made on gases released by a thermal analyzer.

From PerkinElmer 18 Jan 2010

Olympus launches its modular ENDOALPHA endoscopy solution at Labs Global Showcase Awards

Olympus is showcasing its modular ENDOALPHA endoscopy solution within the latest Living Labs Global Showcase Awards. Living Labs Global is a non-profit association aiming to promote digital service innovations to a worldwide audience.

From Olympus Life Science Solutions 8 Jan 2010

Pixel and Panasonic Shikoku Electronics collaborate in the development of PixelOptics' electronic eyeglasses

PixelOptics, Inc. ("Pixel") of Roanoke, Virginia announced today that Pixel and Panasonic Shikoku Electronics Co., Ltd ("Panasonic Shikoku Electronics") of Matsuyama, Japan have been collaborating in the development of PixelOptics' electronic eyeglasses. Pixel, the world's first composite ophthalmic lens company, is developing, and plans to market and sell both static (fixed focus) and electronic dynamic (changeable focus) lenses. Pixel launched atLast!® its first static composite enhanced multifocal in November of 2008. Panasonic Shikoku Electronics is one of group companies of Panasonic Corporation. Panasonic Corporation is a global electronics company and is well known around the world.

From PHC Europe B.V. 6 Jan 2010

Thermo Fisher Scientific announces final results of its 2.50% Convertible Senior Notes offer

Thermo Fisher Scientific Inc. announced today the expiration and final results of the company’s previously announced tender offer (the “Offer”) to purchase for cash any and all of its outstanding 2.50% Convertible Senior Notes due 2023 (the “Convertible Notes”). The Offer expired at 12:00 midnight, New York City time, at the end of Thursday, December 17, 2009.

From Thermo Fisher Scientific Inc. 19 Dec 2009

Roche Diagnostics and Takara Bio enter into license agreement

Roche Diagnostics and Takara Bio, the Shiga (Japan)-based supplier of systems for use in life science research, announced that they have entered into a license agreement for use of the melting curve analysis technology and SYBR Green techniques in their Kits and Instruments for Real Time PCR.

From Roche Diagnostics Limited 18 Dec 2009

Thermo Fisher Scientific selected as NCS biological and environmental sample repository partner

Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has been selected as the National Children’s Study (NCS) biological and environmental sample repository partner. The study examines the effects of environmental influences on the health and development of 100,000 children across the United States, following them from before birth until age 21.

From Thermo Fisher Scientific Inc. 17 Dec 2009

MDS served with a Notice of Application

MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that it was served with a Notice of Application (the "Notice") from PerkinElmer, Inc., with whom MDS has a joint-venture to develop, manufacture and sell inductively coupled plasma mass spectrometers (ICP/MS).

From PerkinElmer 14 Dec 2009

Roche Diagnostics launches new customer training center in Pleasanton, California

Roche Diagnostics announced today the opening of a new west-coast customer training center in Pleasanton, California, as part of an initiative to make state-of-the-art training on diagnostic equipment more accessible to hospitals and independent laboratories on the west and east coasts.

From Roche Diagnostics Limited 8 Dec 2009

PerkinElmer introduces new tools to improve life sciences research

PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the introduction of a wide range of new tools to improve the speed and effectiveness of life sciences research.

From PerkinElmer 5 Dec 2009